Skip to main content
. 2015 Jan 6;465(Pt 2):271–279. doi: 10.1042/BJ20141165

Figure 4. Bosutinib and dasatinib do not affect the TLR-stimulated phosphorylation of CREB.

Figure 4

Bone-marrow-derived macrophages were treated with vehicle control, 3 μM bosutinib, 0.3 μM dasatinib or 0.5 μM HG-9-91-01 for 1 h and then stimulated with LPS for 0, 10, 30, or 60 min. Cell lysates were immunoblotted using the indicated antibodies.